US equities
|
MU
$1,066.49
▼-1.98%
NVDA
$236.03
▼-0.61%
PLTR
$201.68
▲+3.89%
SNDK
$1,646.71
▼-2.70%
META
$720.92
▼-0.05%
AMD
$636.97
▼-1.38%
TSLA
$372.23
▼-1.48%
INTC
$109.95
▼-2.80%
MU
$1,066.49
▼-1.98%
NVDA
$236.03
▼-0.61%
PLTR
$201.68
▲+3.89%
SNDK
$1,646.71
▼-2.70%
META
$720.92
▼-0.05%
AMD
$636.97
▼-1.38%
TSLA
$372.23
▼-1.48%
INTC
$109.95
▼-2.80%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Bausch + Lomb Corporation Common Shares
(NY:
BLCO
)
17.21
-0.13 (-0.73%)
Delayed Quote
Updated: 10:17 AM EDT, Oct 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bausch + Lomb Corporation Common Shares
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Bausch + Lomb Announces Launch of Senior Secured Notes Offering and Refinancing of Credit Agreement
June 10, 2025
From
Bausch + Lomb Corporation
Via
Business Wire
3 Value Stocks in Hot Water
June 10, 2025
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are...
Via
StockStory
3 Stocks Under $50 with Questionable Fundamentals
June 09, 2025
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some...
Via
StockStory
BLCO Investors Have Opportunity to Join Bausch + Lomb Corporation Fraud Investigation with the Schall Law Firm
June 06, 2025
From
The Schall Law Firm
Via
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
June 06, 2025
From
Pomerantz LLP
Via
GlobeNewswire
3 of Wall Street’s Favorite Stocks with Mounting Challenges
June 05, 2025
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...
Via
StockStory
Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities
June 04, 2025
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:OTLK),(NASDAQ:EYEN),(NYSE:BLCO),(NASDAQ:BMEA) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Bausch + Lomb Launches Blink® Nourish Lubricating Eye Drops and Blink Boost Lubricating Eye Drops in the United States
June 04, 2025
From
Bausch + Lomb Corporation
Via
Business Wire
Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities
June 04, 2025
From
FN Media Group LLC
Via
GlobeNewswire
1 Safe-and-Steady Stock for Long-Term Investors and 2 to Question
June 03, 2025
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Via
StockStory
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
June 02, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019
↗
May 29, 2025
FDA approves Alcon's Tryptyr for dry eye disease, backed by Phase 3 trials showing strong efficacy in increasing natural tear production.
Via
Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
May 28, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Bausch + Lomb, Organon, Globalstar, Telephone and Data Systems, and nLIGHT Shares Skyrocket, What You Need To Know
May 27, 2025
A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +1.5%) as President Trump postponed the planned 50% tariff on European Union imports,...
Via
StockStory
Topics
Government
Stocks
World Trade
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
May 22, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference
May 22, 2025
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces 2025 Annual Meeting of Shareholders Results
May 21, 2025
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches New LUMIFY® Preservative Free Redness Reliever Eye Drops in the United States
May 21, 2025
From
Bausch + Lomb Corporation
Via
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
May 18, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Icahn Ramps Up Bets On Genes And Jets: Illumina Stake Jumps 450%, JetBlue Holding Grow 90%
↗
May 16, 2025
Carl Icahn boosts holdings in Illumina and JetBlue, showing confidence in biotech and airlines. He also trims exposure to Southwest Gas Holdings.
Via
Benzinga
Bausch + Lomb Launches Zenlens® CHROMA HOA™ in the United States
May 14, 2025
From
Bausch + Lomb Corporation
Via
Business Wire
BLCO Q1 Earnings Call: Misses on Profit, Highlights Product Innovation and Tariff Uncertainty
May 14, 2025
Eyecare company Bausch + Lomb (NYSE:BLCO) fell short of the market’s revenue expectations in Q1 CY2025 as sales rose 3.5% year on year to $1.14 billion. On the other hand, the company’s full-year...
Via
StockStory
Topics
World Trade
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
May 13, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
May 09, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
May 08, 2025
From
Glancy Prongay & Murray LLP
Via
Business Wire
Bausch + Lomb Corporation (BLCO) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
May 08, 2025
From
Law Offices of Howard G. Smith
Via
Business Wire
3 Profitable Stocks Walking a Fine Line
May 08, 2025
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...
Via
StockStory
Topics
Economy
Supply Chain
Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
May 07, 2025
From
Law Offices of Frank R. Cruz
Via
Business Wire
Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens
May 07, 2025
From
Bausch + Lomb Corporation
Via
Business Wire
Why Bausch + Lomb (BLCO) Shares Are Falling Today
April 30, 2025
Shares of eyecare company Bausch + Lomb (NYSE:BLCO) fell 21.2% in the morning session after the company reported weak first quarter 2025 results: constant currency revenue fell short of Wall Street's...
Via
StockStory
Topics
Initial Public Offering
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
